ImmunityBio,

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ImmunityBio, and other ETFs, options, and stocks.

About IBRX

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. 

CEO
Richard Adcock
CEORichard Adcock
Employees
587
Employees587
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2014
Founded2014
Employees
587
Employees587

IBRX Key Statistics

Market cap
1.94B
Market cap1.94B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
4.05M
Average volume4.05M
High today
$4.97
High today$4.97
Low today
$4.61
Low today$4.61
Open price
$4.96
Open price$4.96
Volume
1.38M
Volume1.38M
52 Week high
$10.88
52 Week high$10.88
52 Week low
$2.60
52 Week low$2.60

IBRX Earnings

-$0.26
-$0.17
-$0.09
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.